2018
Demková K, Kozárová M, Malachovská M, Javorský M, Tkáč I. Osteoprotegerin concentration is associated with the presence and severity of peripheral arterial disease in type 2 diabetes mellitus. Vasa 2018;47:131-135. IF 2017 1,210
Kozárová M, Malachovská Z, Židzik J, Javorský M, Demková K, Habalová V, Tkáč I. Risk allele of gene variant rs6584389 is associated with increased intima-media thickness in patients with type 2 diabetes. Vasa 2018;47:279-284. IF 2017 1,210
2017
Gotthardová I, Javorský M, Klimčáková L, Kvapil M, Schroner Z, Kozárová M, Malachovská M, Ürgeová A, Židzik J, Tkáč I. KCNQ1 gene polymorphism is associated with glycaemic response to treatment with DPP-4 inhibitors. Diabetes Res Clin Pract 2017;130:142-147. IF 2017 2.548
2016
Javorský M, Gotthardová I, Klimčáková L, Kvapil M, Židzik J, Schroner Z, Doubravová P, Gaľa I, Dravecká I, Tkáč I. A missense variant in GLP1R gene is associated with the glycaemic response to treatment with gliptins. Diabetes, Obesity and Metabolism. – ISSN 1463-1326. – Vol. 18, no. 9 (2016), s. 941-944. IF 6,198
Tkáč I, Gotthardová I. Pharmacogenetic aspects of the treatment of Type 2 diabetes with the incretin effect enhancers. Pharmacogenomics. – ISSN 1462-2416. – Vol. 17, no. 7 (2016), s. 795-804. IF 2,710
Zaharenko L, Kalnina I, Geldnere K, Konrade I, Solveiga G, Židzik J, Javorský M, Lejnieks A, Nikitina-Zake L, Fridmanis D, Peculis R, Radovica-Spalvina I, Hartmane D, Pugovics O, Tkáč I, Klimčáková L, Pigags V, Klovins J. Single nucleotide polymorphisms in the intergenic region between metformin transporter OCT2 and OCT3 coding genes are associated with short-term response to metformin monotherapy in type 2 diabetes mellitus patients . European Journal of Endocrinology. – ISSN 0804-4643. – Vol. 175, no. 6 (2016), s. 531 – 540. IF 3,892
Zhou K, Soong Y, …Tkáč I, Javorský M, Židzik J…, Giacomini K, Pearson ER. Variation in the glucose transporter gene SLC2A2 is associated with glycemic response to metformin. Nature Genetics. – ISSN 1061-4036. – Vol. 48, no. 9 (2016), s. 1055 – 1061. IF 31,616
Tkáč I, Raz I. Combined Analysis of Three Large Interventional Trials With Gliptins Indicates Increased Incidence of Acute Pancreatitis in Patients With Type 2 Diabetes. Diabetes Care. – ISSN 0149-5992. – Vol. 40, no. 2 (2017), s. 284 – 286. IF 8,934
2015
Tkáč I, Javorský M, Klimčáková L, Židzik J, Gaľa I, Babjaková E, Schroner Z, Štolfová M, Hermanová H, Habalová V. A pharmacogenetic association between a variation in calpain 10 (CAPN10) gene a the response to metformin treatment in patients with type 2 diabetes. Eur J Clin Pharmacol 2015;71(1):59-63. IF 2.966
Tkáč I. Genetics of drug response in type 2 diabetes. Curr Diab Rep 2015;15:617. IF 3.080
2014
Tisko R, Sopkova Z, Habalova V, Dorkova Z, Slaba E, Javorsky M, Tkac I, Riha RL, Tkacova R. Effects of APOE genotype on serum lipids in obstructive sleep apnoea. Eur Respir J 2014;43(4):1097-1105. IF 2014 7.636
2013
Becker ML, Pearson ER, Tkáč I. Pharmacogenetics of oral antidiabetic drugs. Int J Endocrionol 2013;2013, Art. 686315: 10 pp. IF 2.518
Tkáč I. Cardiovascular Importance of Hyperglycemia and Hypoglycemia. Diabetes Care 2013;36(Suppl 2):S267-S271. IF 7.735
Tkáč I, Klimčáková L, Javorský M, Fabianova M, Schroner Z, Hermanová H, Babjaková E, Tkáčová R. Pharmacogenomic association between a variant in SLC47A1 gene and therapeutic response to metformin in type 2 diabetes. Diabetes Obes Metab 2013;15(2):189-191. IF 5.181
Javorský M, Babjaková E, Klimčáková L, Schroner Z, Židzik J, Štolfová M, Šalagovič J, Tkáč I. Association study between TCF7L2 genotype and glycemic control in diabetic patients treated with gliclazide. Int J Endocrinol 2013;2013, Art. 374858: 5 pp. IF 2.518
Tkacova R, Ukropec J, Skyba P, Ukropcova B, Pobeha P, Kurdiova T, Joppa P, Klimes I, Tkac I, Gasperikova D. Effects of Hypoxia on Adipose Tissue Expression of NFκB, IκBα, IKKγ and IKAP in Patients with Chronic Obstructive Pulmonary Disease. Cell Biochem Biophys 2013;66(1):7-12. IF 1.912
Szaboova E, Holoubek D, Tomori Z, Szabo P, Donic V, Stancak B. Severity of nocturnal cardiac arrhythmias correlates with intensity of sleep apnea in men. Adv Exp Med Biol. 2013;755:155-168. IF 1.825
2012
Javorsky M, Klimcakova L, Schroner Z, Zidzik J, Babjakova E, Fabianova M, Kozarova M, Tkacova R, Salagovic J, Tkac I. KCNJ11 gene E23K variant and therapeutic response to sulfonylureas. Eur J Intern Med 2012;23(3):245-249. IF 2.000
Schroner Z, Javorský M, Halušková J, Klimčáková L, Babjaková E, Fabianová M, Slabá E, Kozárová M, Tkáč I. Variation in CDKAL1 gene is associated with therapeutic response to sulphonylureas. Physiol Res 2012;61(2):177-183. IF 1.555
Tkáč I. Highlights from the latest articles in pharmacogenomics of oral antidiabetic drugs. Pharmacogenomics 2012;13(12):1329-1332. IF 3.974
Brúsik M, Ukropec J, Joppa P, Ukropcová B, Skyba P, Baláž M, Pobeha P, Kurdiová T, Klimeš I, Tkáč I, Gašperíková D, Tkáčová R. Circulatory and adipose tissue leptin and adiponectin in relationship to resting energy expenditure in patients with chronic obstructive pulmonary disease. Physiol Res 2012;61(5):469-480; IF 1.555
Lukan N, Racz O, Paulovicova E, Mocnejova I, Petrovicova J. Determination of immunological stress and oxygen free radical formation in white blood cells during allergen immunotherapy. Med Sci Monit. 2012;18(7):PR13-7. IF 1.699
2011
Schroner Z, Javorsky M, Tkacova R, Klimcakova L, Dobrikova M, Habalova V, Kozarova M, Zidzik J, Rudikova M, Tkac I. Effect of sulphonylurea treatment on glycaemic control is related to TCF7L2 genotype in patients with type 2 diabetes. Diabetes Obes Metab 2011;13(1):89-91. IF 3.379
Tkacova R, Ukropec J, Skyba P, Ukropcova B, Pobeha P, Kurdiova T, Joppa P, Klimes I, Tkac I, Gasperikova D. Increased adipose tissue expression of proinflammatory CD40, MKK4 and JNK in patients with very severe chronic obstructive pulmonary disease. Respiration 2011;81:386-393. IF 2.258
Pobeha P, Ukropec, Skyba P, Ukropcova B, Joppa P, Kurdiova T, Javorsky M, Klimes I, Tkac I, Gasperikova D, Tkacova R. Relationship between osteoporosis and adipose tissue leptin and osteoprotegerin in patients with chronic obstructive pulmonary disease. Bone 2011;48(5):1008-1014. IF 4.023
Schroner Z, Dobrikova M, Klimcakova L, Javorsky M, Zidzik J, Kozarova M, Hudakova T, Tkacova R, Salagovic J, Tkac I. Variation in KCNQ1 is associated with therapeutic response to sulphonylureas. Med Sci Monit 2011;17(7):CR392-396. IF 1.699
2010
Skyba P, Ukropec J, Pobeha P, Ukropcova B, Joppa P, Kurdiova T, Stroffekova K, Brusik M, Klimes I, Tkac I, Gasperikova D, Tkacova R. Metabolic phenotype and adipose tissue inflammation in patients with chronic obstructive pulmonary disease. Mediators Inflamm 2010; Article ID 173498, 9 pages. IF 3.263
Szaboova E, Tomori Z, Szabo P, Gresova S, Donic V. Severe nocturnal cardiac arrhythmias caused by sleep apnea-induced hypoxemia in males. Eur J Med Res. 2010;15(Suppl 2):193-1977. IF 0.978
2009
Habálová V, Klimčáková L, Židzik J, Tkáč I. Rapid and cost effective genotyping method for polymorphisms in PPARG, PPARGC1 and TCF7L2 genes. Mol Cell Probe 2009;23:52-54. IF 2.078
Tkáč I, Miličević Z, Jermendy G. How to interprete the results of the HEART2D trial? Diabetes Res Clin Pract. 2009;86(Suppl 1):S53-S56. IF 2.754
Tkáč I. Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials. Diabetes Res Clin Pract. 2009;86(Suppl 1):S57-S62. IF 2.754
2008
Tkáčová R, Dorková Z, Molčányiová A, Radíková Ž, Klimeš I, Tkáč I. Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea. Med Sci Monit 2008;14(9):CR438-444. IF 1.699
Lukán N, Rácz O, Mocnejová I, Tkáč I. Monitoring antioxidant enzymes in red cells during allergen immunotherapy. J Physiol Biochem 2008;64(2):143-148. IF 1.357
